Andor Glaudemans
prof. dr.
I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
Fetal dose minimization: ultra-low dose long axial field of view (LAFOV) PET/CT imaging of a pregnant patient
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document
10.1007/s00259-024-06861-0
document
Clinical Performance Comparison of a Long Versus a Short Axial Field-of-View PET/CT Using EARL-Compliant Reconstructions
Published in: Molecular Imaging and Biology
Access to document
10.1007/s11307-024-01939-5
document
PURPOSE: To ensure comparable PET/CT image quality between or within centres, clinical inter-system performance comparisons following European Association of Nuclear Medicine Research Ltd. (EARL) guidelines is required. In this work the performance of the long axial field-of-view Biograph Vision Quadra is compared to its predecessor, the short axial field-of-view Biograph Vision. PROCEDURES: To this aim, patients with suspected tumour lesions received a single weight-based (3 MBq/kg) 2-deoxy-2-[ 18F]fluoro-D-glucose injection and underwent routine clinical ( ∼ 15 min) scans on the Vision and 3-min scans on the Quadra in...
Performance of [18F]FDG PET/CT in Diagnosing Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and a Bivariate Meta-Analysis
Published in: Diagnostics
Access to document
10.3390/diagnostics14151603
document
BACKGROUND: Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography ([ 18F]FDG PET/CT) has been suggested as a useful imaging method for diagnosing cyst infections in patients with autosomal dominant polycystic kidney disease (ADPKD). The aim of this article is to provide evidence-based data in this setting. METHODS: A systematic literature review (exploring several bibliographic databases) and a bivariate meta-analysis were carried out to calculate the pooled diagnostic performance of [ 18F]FDG PET/CT in diagnosing probable cyst infection in ADPKD. RESULTS: Ten studies (282 PET/CT scans and 249 patients) were included...
Giorgio Treglia, Domenico Albano, Alessio Rizzo, Antonio Bellasi, Andor W J M Glaudemans, Olivier Gheysens
Nuclear medicine practice for the assessment of cardiac sarcoidosis and amyloidosis: A survey endorsed by the EANM and EACVI
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document
10.1007/s00259-024-06727-5
Irene Gotuzzo, Riemer H J A Slart, Alessia Gimelli, Nabila Ashri, Constantinos Anagnostopoulos, Jan Bucerius, Ronny R Buechel, Oliver Gaemperli, Olivier Gheysens, Andor W J M Glaudemans, Gilbert Habib, Fabian Hyafil, Mark Lubberink, Antti Saraste, Tomaz Podlesnikar, Marc R Dweck, Paola A Erba
Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance
Published in: European Journal of Nuclear Medicine and Molecular Imaging
Access to document
10.1007/s00259-024-06693-y
document
PURPOSE: Consensus on the choice of the most accurate imaging strategy in diabetic foot infective and non-infective complications is still lacking. This document provides evidence-based recommendations, aiming at defining which imaging modality should be preferred in different clinical settings. METHODS: This working group includes 8 nuclear medicine physicians appointed by the European Association of Nuclear Medicine (EANM), 3 radiologists and 3 clinicians (one diabetologist, one podiatrist and one infectious diseases specialist) selected for their expertise in diabetic foot. The latter members formulated some clinical questions that are not...
Chiara Lauri, Edel Noriega-Álvarez, Riddhika M Chakravartty, Olivier Gheysens, Andor W J M Glaudemans, Riemer H J A Slart, Thomas C Kwee, Frédéric Lecouvet, Emmanouil Panagiotidis, Jules Zhang-Yin, Jose Luis Lazaro Martinez, Benjamin A Lipsky, Luigi Uccioli, Alberto Signore